ondasdechoque.org
PT-BR

Adding lidocaine injection to radial shockwaves · Randomized trial · 2022

Does shockwave, with or without a lidocaine injection, ease upper-shoulder muscle pain?

In this trial, both shockwave groups had less pain and neck disability than standard care (heat and exercise) after four weeks. Adding a lidocaine injection just before shockwave eased pain further, at one and four weeks, but did not clearly improve disability more.

Helped more than standard care at 4 weeks
adults with long-lasting upper-shoulder muscle pain
45
shockwave sessions, one a week
3
weeks of follow-up
4

Good to know: Both shockwave groups also had home exercise and posture advice.

Anwar N, Li S, Long L, et al. American Journal of Translational Research, 2022 · Read the paper ↗

How this study worked

Shockwave +lidocaine…15 peopleShockwave15 peopleStandard care15 people
People were assigned to the groups by lot. Each dot is one person.

The treatment

Shockwave

Radial, once a week for 3 weeks

Radial wavesSpread out from the skin; strongest near the surface
Sessions
3, one a week
Pulses
1,000 per point
Strength
1.2bar · 5 per second
Numbing
Not mentioned
Device
Power Shocker LGT-2500
Everyone also got
Home exercise and posture advice

Shockwave + lidocaine injection

Radial, once a week for 3 weeks

Radial wavesSpread out from the skin; strongest near the surface
Sessions
3, one a week
Pulses
1,000 per point
Strength
1.2bar · 5 per second
Numbing
Local anaesthetic · an ultrasound-guided lidocaine injection into the trigger point just before shockwave
Device
Power Shocker LGT-2500
Everyone also got
Home exercise and posture advice

Compared with: Standard care: heat and supervised exercise every other day for two weeks, plus stretching and posture advice

Settings are what each study used, not a prescription.

Who took part

45 adults aged 20–65 with neck pain for over three months and one or two trigger points in the upper trapezius, treated at a rehabilitation department in China; 41 were analysed.

hollow squares: no final score

Shockwave + lidocaine injection15 people
Shockwave13 of 15 measured
Standard care13 of 15 measured
41 of 45 people (91%) had a final score.

Side effects

Some people had mild redness and soreness after the injection. Nothing serious was reported.

All the numbers and the full appraisal
FROM THE FULL PAPER

What the full paper reports.

Adults aged 20–65 with neck pain over three months, VAS at least 3 and one or two upper-trapezius trigger points on either/both sides; radiculopathy and structural cervical disease were excluded. Recruitment occurred at a Chinese rehabilitation department during 2020–2021.

Standard care15randomized

15 randomized; 13 completed/analyzed.

Radial shockwaves15randomized

15 randomized; 13 completed/analyzed.

Shockwaves plus injection15randomized

15 randomized; 15 completed/analyzed.

Pain intensity1 reported outcome
01
Four weeks

Pain intensity

Pain intensity Narrative finding

REPORTED COMPARISON TESTp <0.05

Combined versus shockwave alone

Reported ANOVA comparison

Combined group favored; exact effect and CI are not tabulated.

Analysis details and source

Source provides p-value thresholds and unlabeled bars; no exact mean, SD or effect CI invented.

Elastic stiffness1 reported outcome
02
Four weeks

Elastic stiffness

Elastic stiffness Narrative finding

REPORTED COMPARISON TESTp <0.01

Combined versus shockwave alone

Reported ANOVA comparison

Combined group favored in elastography; surrogate clinical significance uncertain.

Analysis details and source

Source provides p-value thresholds and unlabeled bars; no exact mean, SD or effect CI invented.

Neck disability1 reported outcome
03
Four weeks

Neck disability

Neck disability Narrative finding

REPORTED COMPARISON TESTp <0.01

Each active group versus control

Reported ANOVA comparison

Both active treatments reduced neck disability more than control (standard care) at one and four weeks (P<0.01). The Results and Figure 4 show no significant difference between the combined and shockwave-only groups, although the Discussion says the combination improved functional disability more than shockwave alone.

Analysis details and source

Source provides p-value thresholds and unlabeled bars; no exact mean, SD or effect CI invented.

Surface EMG1 reported outcome
04
Four weeks

Surface EMG

Surface EMG Narrative finding

REPORTED COMPARISON TESTp >0.05

Across groups

Reported ANOVA comparison

No significant between-group or within-group changes.

Analysis details and source

Source provides p-value thresholds and unlabeled bars; no exact mean, SD or effect CI invented.

Skin temperature1 reported outcome
05
Four weeks

Skin temperature

Skin temperature Narrative finding

REPORTED COMPARISON TESTp <0.01

Each active group versus control

Reported ANOVA comparison

Temperature decreased relative to control at four weeks; no between-group difference at one week.

Analysis details and source

Source provides p-value thresholds and unlabeled bars; no exact mean, SD or effect CI invented.

Pain at one week1 reported outcome
06
One week from baseline, while the three weekly sessions were still under way

Pain at one week

VAS Reported comparison

Combined treatment reduced pain compared with control and shockwaves alone (both p<.01); shockwaves alone did not significantly differ from control.

Analysis details and source

Means were graphically presented without exact labels; no numeric means invented.

How treatment was delivered
Combined and shockwave regimen

Power Shocker LGT-2500 radial device: 1,000 pulses per point, 5 Hz, 1.2 bar, once weekly for three sessions. Combined care added ultrasound-guided injection immediately before ESWT on the same day; the source describes 3 mL of 0.5% lidocaine and 0.5% normal saline, an unusual formulation description that requires clarification. Both active groups received home exercise/posture guidance.

Standard care

Standard care included heat and supervised exercise on alternate days for two weeks plus self-stretching/postural guidance. No injection-only or sham-injection arm was used.

HARMS & TOLERABILITY

Results claim no adverse effects, but Discussion explicitly reports mild redness and soreness after injection in some patients, without counts; no serious events were reported. Funding came from NSFC and Chongqing/hospital programs; no conflicts were declared.

LIMITS OF THE ANALYSIS

Small completer sample, four-week follow-up, no injection-only or sham arm and uncertain blinding limit causal attribution to the combination. Surrogate imaging changes do not establish long-term function. Some repeated panels appear inconsistent, especially EMG between-group versus within-group bar heights; exact values were not estimated from graphics. Safety statements conflict.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • Small completer sample, four-week follow-up, no injection-only or sham arm and uncertain blinding limit causal attribution to the combination. Surrogate imaging changes do not establish long-term function. Some repeated panels appear inconsistent, especially EMG between-group versus within-group bar heights; exact values were not estimated from graphics. Safety statements conflict.
Research review

Source-linked critical reading

Single-blind prospective randomized trial, computer-generated allocation in sealed packets. Forty-five participants were randomized equally; 41 completed and were analyzed: 13 control, 13 shockwave, 15 combined. Masking of subjective treatment experiences was not feasible.

Reading depthMaterial consulted
Technical source record

Full local PDF read; All 15 PDF pages; Methods; Results; Table1; Figures1–7 and captions; Figures3–6 visually inspected, pages188–190; Discussion; safety contradiction; limitations; funding; conflicts; references

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Study design

Single-blind prospective randomized trial, computer-generated allocation in sealed packets. Forty-five participants were randomized equally; 41 completed and were analyzed: 13 control, 13 shockwave, 15 combined. Masking of subjective treatment experiences was not feasible.

Participants and setting

Adults aged 20–65 with neck pain over three months, VAS at least 3 and one or two upper-trapezius trigger points on either/both sides; radiculopathy and structural cervical disease were excluded. Recruitment occurred at a Chinese rehabilitation department during 2020–2021.

Treatment protocol

Power Shocker LGT-2500 radial device: 1,000 pulses per point, 5 Hz, 1.2 bar, once weekly for three sessions. Combined care added ultrasound-guided injection immediately before ESWT on the same day; the source describes 3 mL of 0.5% lidocaine and 0.5% normal saline, an unusual formulation description that requires clarification. Both active groups received home exercise/posture guidance.

Comparison

Standard care included heat and supervised exercise on alternate days for two weeks plus self-stretching/postural guidance. No injection-only or sham-injection arm was used.

What was measured

Primary pain VAS 0–10, Neck Disability Index, surface EMG root-mean-square activity, shear-wave elastography in kPa and skin temperature were measured at baseline, one and four weeks. Numerical group means are shown as unlabeled bars rather than a full outcome table; exact means and uncertainty cannot be transcribed reliably.

Results and interpretation

At four weeks combined treatment had less pain than shockwaves alone (p<.05) and less stiffness (p<.01). Both active groups had lower pain and disability than control (p<.01), but no demonstrated combined-versus-shockwave disability advantage is reported. Surface EMG did not differ between or within groups (p>.05). Temperature differed from control at four weeks, not one week.

Harms and disclosures

Results claim no adverse effects, but Discussion explicitly reports mild redness and soreness after injection in some patients, without counts; no serious events were reported. Funding came from NSFC and Chongqing/hospital programs; no conflicts were declared.

Limitations

Small completer sample, four-week follow-up, no injection-only or sham arm and uncertain blinding limit causal attribution to the combination. Surrogate imaging changes do not establish long-term function. Some repeated panels appear inconsistent, especially EMG between-group versus within-group bar heights; exact values were not estimated from graphics. Safety statements conflict.

Applicability

This concerns selected chronic upper-trapezius pain and a combined invasive/noninvasive package. It does not show whether lidocaine alone would perform similarly or whether additional pain relief persists beyond four weeks.

What stronger evidence needs

Provide numerical datasets, resolve duplicate-plot and injection-formulation inconsistencies, include injection-only and credible sham comparisons, analyze all randomized patients and follow clinical function and harms for several months.

THE ORIGINAL SOURCE

Read the original article.

Combined effectiveness of extracorporeal radial shockwave therapy and ultrasound-guided trigger point injection of lidocaine in upper trapezius myofascial pain syndrome.

Anwar N, Li S, Long L, Zhou L, Fan M, Zhou Y, Wang S, Yu L. · American journal of translational research · 2022

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →